A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
University of Nebraska
Massachusetts General Hospital
St. Petersburg State Pavlov Medical University
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University